In a novel animal study design that mimicked human clinical
trials, researchers
at University of California, San Diego School of Medicine report that long - term treatment
using a small molecule drug that reduces activity of the brain's stress circuitry significantly reduces Alzheimer's disease (AD) neuropathology and prevents onset of cognitive
impairment in a mouse model of the neurodegenerative condition.